FREQUENCY OF HLA-DRB1/DQB1 ALLELES AMONG TYPE 1 DIABETES PATIENTS IN DUHOK, KURDISTAN REGION (IRAQ)

DHIA J. AL-TIMIMI1; SALMA S. SHAFEEQ; IDRIS H. AHMED; RAWAND A.AL-QADI

DHIA J. AL-TIMIMI1 Professor., Department of Medical Chemistry, College of Medicine, University of Duhok, Kurdistan Region, Iraq
SALMA S. SHAFEEQ Teaching Laboratories, Duhok, Kurdistan Region, Iraq.
IDRIS H. AHMED Duhok Diabetes Center, Azadi Teaching Hospital, Duhok, Kurdistan Region, Iraq.
RAWAND A.AL-QADI

Keywords: HLA-DR/DQ Alleles;, Type 1 Diabetes Mellitus;, Kurd Population

Abstract

https://doi.org/10.31386/dmj.2019.13.1.7

Background: A large number of studies have demonstrated that specific alleles at the HLA-DRB1 andHLA- DQB1 loci are strongly associated with type 1 diabetes mellitus (T1DM). This preliminary study investigated the heterogeneity in HLA class 11 genotypes distribution among Kurd patients with type 1 diabetes.

Patients and Methods: The study was conducted at Duhok Diabetes Center, Duhok, Kurdistan Region (Iraq). The study participants comprised 96 unrelated T1DM patients and 48 healthy control subjects. Currently, HLA typing methods are relatively expensive and time consuming. We sought to determine the minimum number of HLA polymorphism among T1DM patients and healthy controls that could define the HLA-DR/DQ alleles relevant to T1DM patients .All participants were typed at a polymerase chain reaction-(PCR) for theDRB1 and DQB1 loci. The association analysis was performed by comparing the frequency of DR/DQ alleles among the diabetic patients with the frequency of alleles in the healthy controls.

Results: Number of specific DR/DQ alleles has been identified and a statistically significant association with diabetes has been established. Compared with the healthy controls, patients were more than two-third as likely to have HLA- DRB1*03and -DRB1*04. HLA- DQB1*02allele was also more frequent in T1DM patients. HLA-DRB1*01,-DQB1*05 and -DQB1*06 were less frequent in T1DM patients.

Conclusions: The data indicate that the HLA-DRB1*03, -DRB1*04 and -DQB1*02 were positively associated with TID and may be the most prone alleles, while the HLA-DRB1*01 followed by-DQB1*05 and -DQB1*06 were negatively associated with TID and may be the most protective alleles.

Downloads

Download data is not yet available.

References

1. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. Type 1 Diabetes Genetics Consortium HLA-DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008; 57:1084-1092.
2. Barker JM, Triolo TM, AlyTA, Baschal EE, Babu SR, Kretowski A, etal.Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening. Diabetes. 2008;57:3152-3155.
3. Morahan G. Insights into type 1 diabetes provided by genetic analyses. CurrOpinEndocrinol Diabetes Obes. 2012;19:263-270.
4. Al-Timimi DJ, Mustafa AH. Prevalence of metabolically obese, normal-weight individuals among first degree relatives of patients with type 2 diabetes. JABHS. 2012;13(3):2-8.
5. Al-Timimi DJ, SalehSF.Prevalence and related factors of asymptomatic hyperglycemia among Kurd in Duhok, Iraq. Duhok Med J. 2009;3(1):73-83.
6. Al-Hassan AA, Mohammad N, Al-GhurabiBH,AbdualElah L. HLA Class I and II Genotyping by PCR-SSO in patients with type 1 diabetes mellitus. The Iraqi Postgraduate Medical J. 2013;12(4).
7. Nauyen C, Varney MD, Harrison LC, Morahan G. Definition of High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Types Using Only Three Single Nucleotide Polymorphisms. Diabetes. 2013;62(6):2135-2140.
8. Kawabata Y,IkegamiH,Kawaguchi Y Fujisawa T, Shintani M, Ono M, et al.Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and –DQ haplotypes to susceptibility to type 1 diabetes. Diabetes.2002;51:545-551.
9. Sanjeevi CB, Hook P, Landin-Olsson M, Kockum I, Dahlquist G, Lybrand TP, et al. DR4 subtypes and their molecular properties in a population-based study of Swedish childhood diabetes. Tissue Antigens. 1996;47:275-283.
10. Aly TA, Ide A, JahromiMM, Barker JM, Fernando MS, Babu SR, et al. Extreme genetic risk for type 1A diabetes. ProcNatlAcadSci USA. 2006; 103:14074-14079.
11. Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, et al.Contribution of selectiveHLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. The Journal of Clinical Endocrinology and Metabolism. 2005;90(9):5104-5109.
12. Atkinson MA, Eisenbarth GS. Type 1 diabetes:new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221-229.
13. Park Y,Eisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab Res Rev. 2001;7:2-11.
14. Katahira M, Ishingo T, Segawa S, Kuzuya-Nagao K. Hara I. Nishisaki T . Reevaluation of human leucocyte antigen DR-DQ haplotypes and genotype in type 1 diabetes in the Japanese population. Hormone Research. 2008;69:284-289.
15. Mohammad AK, Nadar MI, Al-Gurabi BH. Genotyping of HLA Class I and Molecules in Type 2 Diabetic Iraqi patients. IOSR journal of Dental and Medical Sciences. 2014;13(4):44-48.
16. Rabbani A, Abbasi F, Taghvaei M, Rabbani B, Moradi B,Shakiba Y, et al. HLA-DRB ,-DQA, and –DQB Allels and haplotypes in Iranian patients with diabetes mellitus type 1. Pediatr Diabetes. 2013;14(5):366-71.
17. Hirsch D, Narinski R, Klein T, Israel S, Singer . Immunogenetics of HLA class II in Israeli patients with adult-onset type I diabetes mellitus.Hum Immunol. 2007;68:616-622.
18. Honen J, Koeova M, Lipponen K, Sukarova-Angelovska E, Jovanovska A, Knip M. HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia. Hum Immunol. 2009; 70:461-463.